Significant anticonvulsant side-effects in children and adolescents

Area of Science:

• Pediatric Neurology
• Clinical Pharmacology
• Epilepsy Management

Background:

• Anticonvulsant drugs (AEDs) are crucial for managing epilepsy in children and adolescents.
• Understanding the incidence and types of significant side effects (SSE) is vital for optimizing treatment.
• Previous studies may underestimate SSE incidence in real-world clinical practice.

Purpose of the Study:

• To determine the incidence and types of significant side effects (SSE) of anticonvulsant drugs (AEDs) in pediatric epilepsy patients.
• To compare SSE rates between children with and without intellectual disability (ID).
• To assess the impact of multiple AED exposures on SSE.

Main Methods:

• Retrospective review of AED history for 216 children and adolescents with epilepsy.
• Prospective monitoring of current AED therapy for SSE.
• Parental questioning regarding previous AED-related SSE.
• Comparison of SSE incidence based on cognitive status (ID vs. normal cognition).

Main Results:

• SSE occurred in 15% of AED exposures, with 26% of children experiencing at least one SSE.
• Behavioral changes (irritability, aggression, hyperactivity) accounted for 7% of SSE.
• Children with intellectual disability (ID) had a significantly higher incidence of behavioral SSE (28% vs. 6%) compared to those with normal cognition.
• Children with ID were three times more likely to experience behavioral SSE.

Conclusions:

• The true incidence of SSE from AEDs in pediatric epilepsy is higher than suggested by monotherapy trials.
• Children with intellectual disability are at increased risk for behavioral side effects from AEDs.
• Careful monitoring for SSE, particularly behavioral changes, is essential in children with epilepsy, especially those with ID.